[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 243-249

Título :	Hyperforin plasma level as a marker of treatment adherence in the national institutes of health hypericum depression trial
Tipo de documento:	texto impreso
Autores:	Benedetto Vitiello, Autor ; Richard I. Shader, Autor ; Corette B. Parker, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 243-249
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno depresivo mayor, Institutos Nacionales de Salud (EE. UU.), Floroglucinol, Terpenos.
Resumen:	A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results.
Link:	./index.php?lvl=notice_display&id=30909

[artículo] Hyperforin plasma level as a marker of treatment adherence in the national institutes of health hypericum depression trial [texto impreso] / Benedetto Vitiello, Autor ; Richard I. Shader, Autor ; Corette B. Parker, Autor . - 2023 . - pp. 243-249.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 3 (Junio) . - pp. 243-249

Palabras clave:	Trastorno depresivo mayor, Institutos Nacionales de Salud (EE. UU.), Floroglucinol, Terpenos.
Resumen:	A previously reported clinical trial of Hypericum perforatum (St John's wort) in depression did not demonstrate efficacy. We assessed treatment adherence by measuring plasma hyperforin and evaluated the possible impact of adherence on study results.
Link:	./index.php?lvl=notice_display&id=30909